Jazz Pharmaceuticals (JAZZ) EPS (Basic) (2010 - 2026)
Jazz Pharmaceuticals' (JAZZ) quarterly EPS (Basic) came in at $4.74 in Q1 2026, up 412.61% year-on-year from $0.92 in Q1 2025, and up 41.88% quarter-over-quarter from $3.34 in Q4 2025.
Jazz Pharmaceuticals (JAZZ) EPS (Basic) (2010 - 2026) Analysis & Trends
Jazz Pharmaceuticals' EPS (Basic) history runs 16 years deep, the most recent figure standing at $4.74 for Q1 2026.
- On a quarterly basis, EPS (Basic) rose 412.61% year-over-year to $4.74 in Q1 2026; TTM through Mar 2026 was $0.48, a 93.94% decrease from a year earlier, with the FY2025 full-year figure at -$5.83, down 164.16% from the prior year.
- EPS (Basic) improved to $4.74 in Q1 2026 per JAZZ's latest filing, from $3.34 in the prior quarter.
- Across five years, EPS (Basic) topped out at $4.74 in Q1 2026 and bottomed at -$11.74 in Q2 2025.
- The 5-year median for EPS (Basic) is $1.5 (2023), against an average of $0.66.
- Across the five-year window, EPS (Basic) plunged 607.71% in 2022 and soared 1085.32% in 2023, its largest moves.
- Year by year, EPS (Basic) stood at -$3.84 in 2022, then soared by 138.97% to $1.5 in 2023, then surged by 106.75% to $3.09 in 2024, then increased by 7.97% to $3.34 in 2025, then soared by 41.88% to $4.74 in 2026.
- Per Business Quant, the three latest JAZZ EPS (Basic) figures stand at $4.74 (Q1 2026), $3.34 (Q4 2025), and $4.14 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Jazz Pharmaceuticals | 15.81 Bn | 13.96 Bn | 934.80 Mn | 4.74 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.74 |
| Dec 31, 2025 | 3.34 |
| Sep 30, 2025 | 4.14 |
| Jun 30, 2025 | -11.74 |
| Mar 31, 2025 | -1.51 |
| Dec 31, 2024 | 3.09 |
| Sep 30, 2024 | 3.51 |
| Jun 30, 2024 | 2.68 |
| Mar 31, 2024 | -0.23 |
| Dec 31, 2023 | 1.50 |
| Sep 30, 2023 | 2.32 |
| Jun 30, 2023 | 1.66 |
| Mar 31, 2023 | 1.11 |
| Dec 31, 2022 | -3.84 |
| Sep 30, 2022 | -0.27 |
| Jun 30, 2022 | 0.59 |
| Mar 31, 2022 | 0.09 |
| Dec 31, 2021 | -0.54 |
| Sep 30, 2021 | -0.81 |
| Jun 30, 2021 | -6.13 |